10 Pharmacists who are aware of cases of exenatide-associated acute pancreatitis or other serious adverse drug reactions are encouraged to report their findings to MedWatch, the FDAs adverse drug reporting program (www.fda.gov/Safety/MedWatch/ Anti-exenatide Antibodies: In phase III clinical trials, 41% to 49% of patients receiving exenatide developed anti-exenatide antibodies
Retatrutide is commonly reconstituted using Bacteriostatic Water
[DOI] [PMC free article] [PubMed] [Google Scholar] 24.Hirukawa H., Kaneto H., Shimoda M., Kimura T., Okauchi S., Obata A., Kohara K., Hamamoto S., Tawaramoto K., Hashiramoto M., et al
Other treatments including antivirals (Remdesivir, Lopinavir), corticosteroids, and hydroxychloroquine similarly disrupt gut homeostasis
Injection site reactions: Redness, swelling or irritation at the injection site may occur
8 , e1002626 (2012)